Josiane E. Eid

914 total citations
20 papers, 730 citations indexed

About

Josiane E. Eid is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Josiane E. Eid has authored 20 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Josiane E. Eid's work include Sarcoma Diagnosis and Treatment (9 papers), RNA Interference and Gene Delivery (4 papers) and Cancer-related gene regulation (3 papers). Josiane E. Eid is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), RNA Interference and Gene Delivery (4 papers) and Cancer-related gene regulation (3 papers). Josiane E. Eid collaborates with scholars based in United States, China and Finland. Josiane E. Eid's co-authors include Yuejun Kang, Dongqing Li, Spyros A. Kalams, Barbara Sollner-Webb, David M. Livingston, Ralph Scully, Andrew L. Kung, Christian M. Shaffer, B Sollner-Webb and Michael N. VanSaun and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Josiane E. Eid

19 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josiane E. Eid United States 15 304 254 216 144 117 20 730
Song-Chu Ko United States 9 301 1.0× 135 0.5× 96 0.4× 165 1.1× 81 0.7× 20 606
Satoshi Ikeo Japan 8 363 1.2× 266 1.0× 74 0.3× 106 0.7× 18 0.2× 22 679
Alexia Ghazi United States 7 202 0.7× 101 0.4× 215 1.0× 498 3.5× 84 0.7× 11 674
Fan Zou China 13 248 0.8× 52 0.2× 69 0.3× 314 2.2× 23 0.2× 33 653
Yang Feng United States 10 365 1.2× 52 0.2× 270 1.3× 921 6.4× 148 1.3× 25 1.2k
Bianca von Scheidt Australia 16 215 0.7× 63 0.2× 140 0.6× 918 6.4× 38 0.3× 21 1.3k
David B. Weinreb United States 8 152 0.5× 168 0.7× 83 0.4× 97 0.7× 23 0.2× 12 588
Shengji Yu China 14 304 1.0× 104 0.4× 124 0.6× 194 1.3× 7 0.1× 47 763
Molly Wanner United States 12 207 0.7× 61 0.2× 28 0.1× 301 2.1× 28 0.2× 26 794
Marc Wehrli United States 12 360 1.2× 49 0.2× 109 0.5× 363 2.5× 35 0.3× 24 830

Countries citing papers authored by Josiane E. Eid

Since Specialization
Citations

This map shows the geographic impact of Josiane E. Eid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josiane E. Eid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josiane E. Eid more than expected).

Fields of papers citing papers by Josiane E. Eid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josiane E. Eid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josiane E. Eid. The network helps show where Josiane E. Eid may publish in the future.

Co-authorship network of co-authors of Josiane E. Eid

This figure shows the co-authorship network connecting the top 25 collaborators of Josiane E. Eid. A scholar is included among the top collaborators of Josiane E. Eid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josiane E. Eid. Josiane E. Eid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Luyuan, Josiane E. Eid, Wensi Tao, et al.. (2024). High-Throughput Drug Screening in Chondrosarcoma Cells Identifies Effective Antineoplastic Agents Independent of IDH Mutation. International Journal of Molecular Sciences. 25(23). 13003–13003.
2.
Li, Luyuan, Jonathan C. Trent, & Josiane E. Eid. (2023). Optimized lentiviral vector transduction of adherent cells and analysis in sulforhodamine B proliferation and chromatin immunoprecipitation assays. STAR Protocols. 4(1). 102109–102109. 1 indexed citations
3.
Hu, Xiaoyu, Luyuan Li, Josiane E. Eid, et al.. (2022). IDH1 Mutation Induces HIF-1α and Confers Angiogenic Properties in Chondrosarcoma JJ012 Cells. Disease Markers. 2022. 1–11. 10 indexed citations
4.
DeSalvo, Joanna, Yuguang Ban, Luyuan Li, et al.. (2021). ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control. Journal of Clinical Investigation. 131(13). 24 indexed citations
5.
Li, Luyuan, Xiaoyu Hu, Josiane E. Eid, et al.. (2020). Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth. Cancers. 12(1). 141–141. 18 indexed citations
6.
Li, Luyuan, Josiane E. Eid, Ana C. Paz, & Jonathan C. Trent. (2017). Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy. BioDrugs. 31(5). 379–392. 8 indexed citations
7.
Eid, Josiane E., et al.. (2014). Reprogramming of mesenchymal stem cells by oncogenes. Seminars in Cancer Biology. 32. 18–31. 14 indexed citations
8.
Barham, Whitney, Andrea L. Frump, Taylor P. Sherrill, et al.. (2013). Targeting the Wnt Pathway in Synovial Sarcoma Models. Cancer Discovery. 3(11). 1286–1301. 57 indexed citations
9.
Shaffer, Christian M., et al.. (2012). Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2. BMC Genomics. 13(1). 189–189. 29 indexed citations
10.
Shaffer, Christian M., Maria P. Alfaro, Ashley Smith, et al.. (2011). Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT–SSX2. Oncogene. 31(18). 2323–2334. 54 indexed citations
11.
Eid, Josiane E., et al.. (2009). The Synovial Sarcoma-Associated SYT-SSX2 Oncogene Antagonizes the Polycomb Complex Protein Bmi1. PLoS ONE. 4(4). e5060–e5060. 28 indexed citations
12.
Chittezhath, Manesh, Andrea L. Frump, Jérôme Jourquin, Nichole A. Lobdell, & Josiane E. Eid. (2008). The proto-oncoprotein SYT (SS18) controls ATP release and regulates cyst formation by polarized MDCK cells. Experimental Cell Research. 314(19). 3551–3562. 5 indexed citations
13.
Kang, Yuejun, Dongqing Li, Spyros A. Kalams, & Josiane E. Eid. (2007). DC-Dielectrophoretic separation of biological cells by size. Biomedical Microdevices. 10(2). 243–249. 218 indexed citations
14.
Frump, Andrea L., et al.. (2007). The Synovial Sarcoma SYT-SSX2 Oncogene Remodels the Cytoskeleton through Activation of the Ephrin Pathway. Molecular Biology of the Cell. 18(10). 4003–4012. 25 indexed citations
15.
16.
Eid, Josiane E., Andrew L. Kung, Ralph Scully, & David M. Livingston. (2000). p300 Interacts with the Nuclear Proto-Oncoprotein SYT as Part of the Active Control of Cell Adhesion. Cell. 102(6). 839–848. 80 indexed citations
17.
Eid, Josiane E. & Barbara Sollner-Webb. (1997). ST-2, a Telomere and Subtelomere Duplex and G-strand Binding Protein Activity in Trypanosoma brucei. Journal of Biological Chemistry. 272(23). 14927–14936. 16 indexed citations
18.
Eid, Josiane E. & Barbara Sollner-Webb. (1995). ST-1, a 39-Kilodalton Protein in Trypanosoma brucei , Exhibits a Dual Affinity for the Duplex Form of the 29-Base-Pair Subtelomeric Repeat and Its C-Rich Strand. Molecular and Cellular Biology. 15(1). 389–397. 31 indexed citations
19.
20.
Eid, Josiane E., et al.. (1988). Gossypol-induced death of African trypanosomes. Experimental Parasitology. 66(1). 140–142. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026